Expertise in
7
conditions

Motoyasu Kato

Tokyo, JP 
Expertise in
7
conditions
Tokyo, JP 

Overview

Motoyasu Kato practices practicing medicine in Tokyo, Japan.

Kato is highly rated in 7 conditions, according to our data. Their clinical expertise encompasses Interstitial Lung Disease, Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, and Pulmonary Fibrosis.

They are actively involved in clinical research, co-authoring 58 peer reviewed articles and participating in 2 clinical trials.

Locations

Tokyo, Japan
Other Locations
Bunkyo, Japan
Hongo, 1138421, Japan
Urayasu, 2730021, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Japanese Idiopathic Interstitial Pneumonias Registry
Japanese Idiopathic Interstitial Pneumonias Registry
Enrollment Status: Active_not_recruiting
Publish Date: February 05, 2026
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
View 1 Less Clinical Trial

58 Total Publications

Prognostic nutritional index predicts nintedanib outcomes in idiopathic pulmonary fibrosis.
Prognostic nutritional index predicts nintedanib outcomes in idiopathic pulmonary fibrosis.
Journal: Therapeutic advances in respiratory disease
Published: August 12, 2026

Frequently Asked Questions about Motoyasu Kato

Is Motoyasu Kato a top-rated expert for Interstitial Lung Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Motoyasu Kato is classified as an Elite expert for Interstitial Lung Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Motoyasu Kato participate in research or clinical trials?

Yes. Motoyasu Kato has published 58 articles and abstracts on conditions like Interstitial Lung Disease. You can view a list of Motoyasu Kato's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kato's expertise for a condition
ConditionClose
View All 26 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile